These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3780420)

  • 21. Clinical experience with molindone hydrochloride in geriatric patients.
    Peper M
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):26-9. PubMed ID: 3894339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molindone and weight loss.
    Heikkinen H; Outakoski J; Meriläinen V; Tuomi A; Huttunen MO
    J Clin Psychiatry; 1993 Apr; 54(4):160-1. PubMed ID: 8486596
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of injectable molindone and haloperidol followed by oral dosage forms in acutely ill schizophrenics.
    Escobar JI; Mann JJ; Keller J; Wilkins J; Mason B; Mills MJ
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):15-9. PubMed ID: 3894337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromocriptine associated with symptom exacerbation during neuroleptic treatment of schizoaffective schizophrenia.
    Frye PE; Pariser SF; Kim MH; O'Shaughnessy RW
    J Clin Psychiatry; 1982 Jun; 43(6):252-3. PubMed ID: 7200978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tardive dyskinesia oral facial dyskinesia with moban.
    Camp EW
    Dis Nerv Syst; 1977 Sep; 38(9):759. PubMed ID: 902566
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined use of molindone and guanethidine in patients with schizophrenia and hypertension.
    Simpson LL
    Am J Psychiatry; 1979 Nov; 136(11):1410-4. PubMed ID: 495792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of morbidly obese psychotic patients with molindone: three case reports.
    McCue RE; Unuigbe FE; Charles RA; Orendain GC; Waheed R
    J Clin Psychiatry; 2009 Nov; 70(11):1606-7. PubMed ID: 20031106
    [No Abstract]   [Full Text] [Related]  

  • 28. Atypical and typical neuroleptics and tardive dyskinesia.
    Borison RL; Shah C; White TH; Diamond BI
    Psychopharmacol Bull; 1987; 23(1):218-20. PubMed ID: 3602323
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
    Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W
    Behav Neuropsychiatry; 1971 Dec; 3(9):6-13. PubMed ID: 4948869
    [No Abstract]   [Full Text] [Related]  

  • 30. Tardive dyskinesia with molindone.
    Ananth J; Carrillo R
    J Clin Psychiatry; 1983 Jul; 44(7):276. PubMed ID: 6863230
    [No Abstract]   [Full Text] [Related]  

  • 31. Tardive dyskinesia associated with molindone treatment.
    Katz SE
    Am J Psychiatry; 1990 Jan; 147(1):124-5. PubMed ID: 2293775
    [No Abstract]   [Full Text] [Related]  

  • 32. Molindone and haloperidol in tardive dyskinesia.
    Glazer WM; Hafez HM; Benarroche CL
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):4-7. PubMed ID: 2862139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic-induced "painful legs and moving toes" syndrome: successful treatment with clonazepam and baclofen.
    Sandyk R
    Ital J Neurol Sci; 1990 Dec; 11(6):573-6. PubMed ID: 2081681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More on galactorrhea associated with molindone.
    Kahn JL
    Am J Psychiatry; 1979 Dec; 136(12):1617-8. PubMed ID: 574364
    [No Abstract]   [Full Text] [Related]  

  • 35. Rhabdomyolysis and molindone.
    Pandurangi AK; Narasimhachari N
    J Clin Psychiatry; 1988 Jan; 49(1):37-8. PubMed ID: 3335489
    [No Abstract]   [Full Text] [Related]  

  • 36. A phase 2a randomized, parallel group, dose-ranging study of molindone in children with attention-deficit/hyperactivity disorder and persistent, serious conduct problems.
    Stocks JD; Taneja BK; Baroldi P; Findling RL
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):102-11. PubMed ID: 22372512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of molindone in treatment-refractory agitated schizophrenia: three case reports.
    Ciranni M; Lindenmayer JP; Gold J
    J Clin Psychiatry; 2008 Jun; 69(6):1018-9. PubMed ID: 18684000
    [No Abstract]   [Full Text] [Related]  

  • 38. Reinstitution of neuroleptic treatment with molindone in a patient with a history of neuroleptic malignant syndrome.
    Slack T; Stoudemire A
    Gen Hosp Psychiatry; 1989 Sep; 11(5):365-7. PubMed ID: 2507394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of molindone and tranylcypromine in the treatment of refractory depression.
    Small JG; Kellams JJ; Dennis JL; Milstein V
    J Clin Pharmacol; 1981; 21(8-9):351-8. PubMed ID: 7276229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhabdomyolysis and acute renal failure.
    Glickman L
    J Clin Psychiatry; 1987 Jul; 48(7):299-300. PubMed ID: 3597334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.